Funding for this research was provided by:
Agence Nationale de la Recherche (10-LABX-69-01)
Institut National de la Santé et de la Recherche Médicale
Swiss National Science Foundation (31003A_175603)
Text and Data Mining valid from 2018-07-27
Received: 15 May 2018
Accepted: 10 July 2018
First Online: 27 July 2018
Ethics approval and consent to participate
: The clinical study was approved by the Comité de Protection des Personnes - Ouest 6 on June 13, 2012 and by the French Agence Nationale de Sécurité du Médicament on June 22, 2012, and has been performed in accordance with the Declaration of Helsinki. The study is sponsored by the Institut Pasteur (Pasteur ID-RCB Number: 2012-A00238-35) and was conducted as a single-center study without any investigational product. The protocol is registered under ExternalRef removed (study# NCT01699893). Informed consent was obtained from participants after the nature and possible consequences of the studies were explained.
: Not applicable.
: C.H. and M.L.A. are employees of Genentech Inc., a member of The Roche Group. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.